Study Reveals Barriers Slowing GM Crop Adoption in India

A new analysis using a SWOT (Strengths, Weaknesses, Opportunities, and Threats) framework sheds light on the complex dynamics shaping the biotechnology future of India. After the approval of Bt cotton in 2002, the commercialization of other genetically modified (GM) crops in the country has been stalled due to socio-political resistance.

The study highlights several strengths, including higher yields, pest resistance, and reduced pesticide use. However, the identified weaknesses, such as poor biosafety infrastructure, fragmented regulation, and limited public awareness, continue to hinder progress in commercialization in India. Despite having opportunities to boost food security, the country also faces threats to biodiversity loss, ethical opposition, and trade barriers.

Findings from case studies on Bt cotton, Bt brinjal, and GM mustard demonstrate that while GM technology can deliver tangible benefits, socio-political resistance and regulatory uncertainty have slowed adoption. The authors concluded that India's progress in agricultural biotechnology will depend on stronger biosafety systems, streamlined regulation, transparent field trials, and active public engagement.

For more information, read the article from NG Agriculture Insights.